The world should be far better prepared for the next Ebola outbreak, with further promising results on Tuesday showing the potential of a long-lasting vaccine against the deadly virus. The vaccine requires one dose to prime the immune system and a second shot to boost the body's response. That is different from another Ebola vaccine from Merck, which was the first to prove effective in preventing human infection during a large trial in Guinea last year. Scientists have been racing to develop vaccines for Ebola after more than 11,300 people died in West Africa's 2013-2016 epidemic. Debating vaccine strategiesRecent progress means experts are now confident the world will not be defenceless when the next outbreak hits.

Source: CBC News March 15, 2017 14:37 UTC